Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence

Addictive Behaviors

Volumn 29, Issue 7, 2004, Pages 1439-1464

  Grabowski, John ^a   Shearer, James ^b   Merrill, John ^c   Negus, S Stevens ^d  

^a Univ Texas Hlth Sci Ctr H   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Pharmacotherapy; Stimulants; Substance dependence

Indexed keywords

AMANTADINE; ARIPIPRAZOLE; ATOMOXETINE; BACLOFEN; BUPRENORPHINE; CARBIDOPA PLUS LEVODOPA; CENTRAL STIMULANT AGENT; CLONIDINE; COCAINE; DESIPRAMINE; DEXAMPHETAMINE; DEXTROMETHORPHAN; DISULFIRAM; DRONABINOL; FLUOXETINE; GABAPENTIN; HYDROMORPHONE; LOFEXIDINE; MECAMYLAMINE; MEMANTINE; METHADONE; MODAFINIL; N ACETYLASPARTIC ACID; NALOXONE; NALTREXONE; PROGESTERONE; PROPRANOLOL; UNINDEXED DRUG; VALPROATE SEMISODIUM; VANOXERINE;

COCAINE DEPENDENCE; CONFERENCE PAPER; DRUG ABUSE; DRUG ANTAGONISM; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; MEDICAL RESEARCH; SUBSTANCE ABUSE;

DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; HUMANS; MODELS, ANIMAL; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 4444324187     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2004.06.018     Document Type: Conference Paper

References (160)

1. A. Baker, and N.K. Lee A review of psychosocial interventions for amphetamine use Drug and Alcohol Review 22 2003 232 336
2. J.C. Ball, and A. Ross The effectiveness of methadone maintenance treatment: Patients, programs, services and outcomes 1991 Springer-Verlag New York
3. R.L. Balster, and C.R. Schuster A comparison of d-amphetamine, l-amphetamine, and methamphetamine self-administration in rhesus monkeys Pharmacology, Biochemistry and Behavior 1 1973 67 71
4. S.L. Batki, J. Moon, K. Delucchi, M. Bradley, D. Hersh, and S. Smolar Methamphetamine quantitative urine concentrations during a controlled trial of fluoxetine treatment. Preliminary analysis Annals of the New York Academy of Sciences 909 2000 260 263
5. S.L. Batki, A.M. Washburn, K. Delucchi, and R.T. Jones A controlled trial of fluoxetine in crack cocaine dependence Drug and Alcohol Dependence 41 2 1996 137 142
6. M.H. Baumann, M.A. Ayestas, L.G. Sharpe, D.B. Lewis, K.C. Rice, and R.B. Rothman Persistent antagonism of methamphetamine-induced dopamine release in rats pretreated with GBR12909 decanoate Journal of Pharmacology and Experimental Therapeutics 301 3 2002 1190 1197
7. M.H. Baumann, J.M. Phillips, M.A. Ayestas, S.F. Ali, K.C. Rice, and R.B. Rothman Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence Annals of the New York Academy of Sciences 965 2002 92 108
8. A. Bisaga, E.V. Nunes, S.K. Vosburg, and M.W. Fischman The prognostic significance of baseline cocaine use in the treatment of cocaine dependence Drug and Alcohol Dependence 66 S2 2002 15
9. G.L. Brown, R.D. Hunt, M.H. Ebert, W.E. Bunney, and I.J. Kopin Plasma levels of d-amphetamine in hyperactive children. Serial behavior and motor responses Psychopharmacology 62 1979 133 140
10. J. Campbell, and E. Nickel Comparison of desipramine or carbamazepine to placebo for crack cocaine-dependent patients American Journal on Addictions 12 2 2003 122 136
11. T. Carnwath, T. Garvey, and J.J. Holland The prescription of dexamphetamine to patients with schizophrenia and amphetamine dependence Journal of Psychopharmacology 16 4 2002 373 377
12. F.I. Carroll, L. Howell, and M.J. Kuhar Pharmacotherapies for treatment of cocaine abuse: Preclinical aspects Journal of Medicinal Chemistry 42 1999 2721 2736
13. K.M. Carroll, C. Nich, S.A. Ball, E. McCance, and B.J. Rounsavile Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram Addiction 93 5 1998 713 727
14. K.M. Carroll, B.J. Rounsavile, L.T. Gordon, C. Nich, P. Jatlow, and R.M. Bisighini Psychotherapy and pharmacotherapy for ambulatory cocaine abusers Archives of General Psychiatry 51 3 1994 177 187
15. B. Charnaud, and V. Griffiths Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: A comparison [published erratum appears in Drug Alcohol Depend 1999 Apr 1; 54(2):179] Drug and Alcohol Dependence 52 1 1998 79 84
16. A. Childress, and C.P. O'Brien Dopamine receptor partial agonists could address the duality of cocaine craving Trends in Pharmacological Sciences 21 1 2000 6 9
17. A. Comacho, and M.B. Stein Modafinil for social phobia and amphetamine dependence (letter) American Journal of Psychiatry 159 11 2002 1947 1948
18. W. Condelli, and J. Fairbank Cocaine use by clients in methadone programs: Significance, scope, and behavioural interventions Journal of Substance Abuse Treatment 8 1991 203 212
19. M. Cousins, D. Roberts, and H. de Wit GABA(B) receptor agonists for the treatment of drug addiction: A review of recent findings Drug and Alcohol Dependence 65 2003 209 220
20. P.W. Czoty, B.C. Ginsburg, and L. Howell Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys Journal of Pharmacology and Experimental Therapeutics 300 2002 831 837
21. Dackis, C., Kampman, K., Pettinati, C., Weigley, M., McAllister, M., & O'Brien, C. (2003). Open-label modafinil treatment for cocaine dependence. In R. Eisenberg (Ed.), The College on Problems of Drug Dependence: Sixtyfifth Annual Scientific Meeting, 2003. Florida: Bal Harbour.
22. C. Dackis, and W.J. Lynch Modafinil and cocaine: A double blind placebo-controlled drug interaction study Drug and Alcohol Dependence 70 2003 29 37
23. C. Dackis, and C. O'Brien Glutamatergic agents for cocaine dependence Annals of the New York Academy of Sciences 1003 2003 328 345
24. A. de Lima, and M.S. Lima Carbamazepine for cocaine dependence 2004 John Wiley and Sons Chichester
25. M.S. de Lima, B.G. Oliveira-Soares, A.A. Reisser, and M. Farrell Pharmacological treatment of cocaine dependence: A systematic review Addiction 97 8 2002 931 949
26. V.P. Dole, M.E. Nyswander, and M.J. Kreek Narcotic blockade Archives of Internal Medicine 118 4 1966 304 309
27. M.W. Emmett-Oglesby, R.L. Peltier, R.Y. Depoortere, C.L. Pickering, M.L. Hooper, and Y.H. Gong Tolerance to self-administration of cocaine in rats: Time course and dose-response determination using a multi-dose method Drug and Alcohol Dependence 32 247-256 1993
28. S.M. Evans, S.L. Walsh, F.R. Levin, R.W. Foltin, M.W. Fischman, and G.E. Bigelow Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans Drug and Alcohol Dependence 64 3 2001 271 283
29. T.C. Fagan Remembering lessons of basic pharmacology Archives of Internal Medicine 154 1994 1430 1431
30. M. Fiore US Public Health Service Clinical Guidelines: Treatment tobacco use and dependence Respiratory Care 45 10 2000 1200 1262
31. P.M. Fleming, and D. Roberts Is the prescription of amphetamine justified as a harm reduction measure? Journal of the Royal Society of Health 114 3 1994 127 131
32. A. Frances, H.A. Pincus, and M.B. First Diagnostic and statistical manual of mental disorders 1994 American Psychiatric Association Washington, DC
33. G.P. Galloway, and J.D. Newman A controlled trial of imipramine for the treatment of methamphetamine dependence Journal of Substance Abuse Treatment 13 6 1996 493 497
34. F.C. Garcia-Ladona, and B.F. Cox BP 897, a selective dopamine D3 receptor ligand with therapeutic potential for the treatment of cocaine-addiction CNS Drug Reviews 9 2 2003 141 158
35. F. Gawin, C. Riordan, and H. Kleber Methylphenidate treatment of cocaine abusers without attention deficit disorder: A negative report American Journal of Drug and Alcohol Abuse 11 3-4 1985 193 197
36. F.H. Gawin, D. Allen, and B. Humblestone Outpatient treatment of 'crack' cocaine smoking with flupenthixol decanoate. A preliminary report Archives of General Psychiatry 46 4 1989 322 325
37. T. George, and M.C. Chawarski Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: A preliminary trial Biological Psychiatry 47 12 2000 1080 1086
38. J.R. Glowa, and W.E. Fantegrossi Effects of dopaminergic drugs on food- and cocaine-maintained responding: IV. Continuous cocaine infusions Drug and Alcohol Dependence 45 1997 71 79
39. J.R. Glowa, W.E. Fantegrossi, D.B. Lewis, D. Matecka, K.C. Rice, and R.B. Rothman Sustained decrease in cocaine-maintained responding in rhesus monkeys with 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-hydroxy-3-phenylpropyl) piperazinyl deconotate, a long acting ester derivative of GBR12909 Journal of Medicinal Chemistry 39 24 1996 4689 4691
40. J.R. Glowa, F.H. Wojnicki, D. Matecka, K.C. Rice, and R.B. Rothman Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: II. Comparisons with other drugs and repeated administrations Experimental and Clinical Psychopharmacology 3 1995 1 8
41. J. Grabowski Dextroamphetamine for cocaine-dependence treatment: A double-blind randomized clinical trial Journal of Clinical Psychopharmacology 21 5 2001 522 526
42. J. Grabowski, H. Rhoades, R. Elk, J. Schmitz, C. Davis, and D. Creson Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: Two placebo-controlled double-blind trials Journal of Clinical Psychopharmacology 15 3 1995 163 174
43. J. Grabowski, H. Rhoades, P. Silverman, J.M. Schmitz, A. Stotts, and D. Creson Risperidone for the treatment of cocaine dependence: Randomized, double-blind trial Journal of Clinical Psychopharmacology 20 3 2000 305 310
44. J. Grabowski, H. Rhoades, A. Stotts, K. Cowan, C. Kopecky, and A. Dougherty Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence. Two double-blind randomized clinical trials Neuropsychopharmacology 2004 (in press)
45. J. Grabowski, J.D. Roache, J.M. Schmitz, H. Rhoades, D. Creson, and A. Korszun Replacement medication for cocaine dependence: Methylphenidate Journal of Clinical Psychopharmacology 17 6 1997 485 488
46. R.R. Griffiths, R.M. Wurster, and J.V. Brady Discrete-trial choice procedure: Effects of naloxone and methadone on choice between food and heroin Pharmacological Reviews 27 1975 357 365
47. M. Haney, and A.S. Ward Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administratoin by humans Psychopharmacologia 155 4 2001 330 337
48. S.E. Harrigan, and D.A. Downs Pharmalogical evaluation of narcotic antagonist delivery systems in rhesus monkeys NIDA Research Monograph 28 1981 77 92
49. C.L. Hart, A.S. Ward, M. Haney, J. Nasser, and R.W. Foltin Methamphetamine attenuates disruptions in performance and mood during simulated night-shift work Psychopharmacology 169 1 2003 42 51
50. C.E. Heading Recent advances, drugs against substance abuse IDrugs 6 7 2003 681 687
51. S.T. Higgins, D.D. Delaney, A.J. Budney, W.K. Bickel, J.R. Hughes, and F. Foerg A behavioral approach to achieving initial cocaine abstinence American Journal of Psychiatry 148 9 1991 1218 1224
52. L. Howell, and L.D. Byrd Characterization of the effects of cocaine and GBR12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey Journal of Pharmacology and Experimental Therapeutics 258 1991 178 185
53. L.L. Howell, and K.M. Wilcox The dopamine transporter and cocaine medication development: Drug self-administration in nonhuman primates Journal of Pharmacology and Experimental Therapeutics 298 1 2001 1 6
54. A.J. Jaffe, B.J. Rounsavile, G. Chang, R.S. Schottenfeld, R.E. Meyer, and S.S. O'Malley Naltrexone, relapse prevention, and supportive therapy with alcoholics: An analysis of patient treatment matching Journal of Consulting and Clinical Psychology 64 5 1996 1044 1053
55. C.E. Johanson, and M.W. Fischman The pharmacology of cocaine related to its abuse Pharmacological Reviews 41 1989 3 52
56. B.E. Jones, and J.A. Prada Effects of methadone and morphine maintenance on drug-seeking behavior in the dog Psychopharmacology 54 1977 109 112
57. K.M. Kampman, and H.R. Pearsall A pilot study of olanzapine for treatment of cocaine dependence Drug and Alcohol Dependence 70 2003 265 273
58. K.M. Kampman, M. Rukstalis, R. Ehrman, D.E. McGinnis, P. Gariti, and J.R. Volpicelli Open trials as a method of prioritizing medications for inclusion in controlled trials for cocaine dependence Addictive Behaviors 24 2 1999 287 291
59. K. Kantak Anti-cocaine vaccines: Antibody protection against relapse Expert Opinion on Pharmacotherapy 4 2 2003 213 218
60. E.J. Khantzian The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence American Journal of Psychiatry 142 11 1985 1259 1264
61. E.J. Khantzian, and F. Gawin Methylphenidate treatment of cocaine dependence: A preliminary report Journal of Substance Abuse Treatment 1 1984 107 112
62. H.D. Kleber Pharmacologic treatments for heroin and cocaine dependence American Journal on Addictions 12 Suppl. 2 2003 S5 S18
63. H. Klee, S. Wright, T. Carnwath, and J. Merrill The role of substitute therapy in the treatment of problem amphetamine use Drug and Alcohol Review 20 2001 417 429
64. M. Klein Research issues related to development of medications for treatment of cocaine addiction Annals of the New York Academy of Sciences 844 1998 75 91
65. M.S. Kleven, and W.L. Woolverton Effects of bromocriptine and desipramine on behavior maintained by cocaine or food presentation in rhesus monkeys Psychopharmacology 101 1990 208 213
66. M.S. Kleven, and W.L. Woolverton Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys Drug and Alcohol Dependence 31 1990 149 158
67. S. Kolins Comparing the abuse potential of methylphenidate versus other stimulants: A review of available evidence and relevance to the ADHD patient Journal of Clinical Psychiatry 64 Suppl. 11 2003 14 18
68. T. Kosten, and E. McCance A review of pharmacotherapies for cocaine dependence American Journal of the Addictions 5 1 1996 58 65
69. T.R. Kosten, T.P. George, and T.A. Kosten The potential of dopamine agonists in drug addiction Expert Opinion on Investigational Drugs 11 4 2002 491 499
70. T.R. Kosten, M. Rosen, J. Bond, M. Settles, J.S. Roberts, and J. Shields Human therapeutic cocaine vaccine: Safety and immunogenicity Vaccine 20 7-8 2002 1196 1204
71. M.J. Kuhar, M.C. Ritz, and J.W. Boja The dopamine hypothesis of the reinforcing properties of cocaine Trends in Neurosciences 14 1991 299 302
72. V.G. Laties, and B. Weiss Performance enhancement by the amphetamines: A new appraisal 1967 Excerpta Medica Foundation Amsterdam
73. V.G. Laties, and B. Weiss The amphetamine margin in sports Federation Proceedings 40 12 1981 2689 2692
74. M.G. LeSage, D.E. Keyler, G. Collins, and P.R. Pentel Effects of continuous nicotine infusion on nicotine self-administration in rats: Relationship between continuously infused and self-administered nicotine doses and serum concentrations Psychopharmacology 170 2003 278 286
75. F.R. Levin, and S.M. Evans Flupenthixol treatment for cocaine abusers with schizophrenia: A pilot study American Journal of Drug and Alcohol Abuse 24 3 1998 343 350
76. F.R. Levin, S.M. Evans, S. Coomaraswammy, E.D. Collins, N. Regent, and H.D. Kleber Flupenthixol treatment for cocaine abusers with schizophrenia: A pilot study American Journal of Drug and Alcohol Abuse 24 3 1998 343 360
77. F.R. Levin, S.M. Evans, D.M. McDowell, and H.D. Kleber Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: A pilot study Journal of Clinical Psychiatry 59 6 1998 300 305
78. D. Lewis, D. Matecka, K. Zhang, L.W. Hsin, C.M. Dersch, and D. Stafford Oxygenated analogues of 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-hydroxy-3- phenylpropyl)piperazinyl (GBR12935 and GBR12909) as potential extended-action cocaine-abuse therapy agents Journal of Medicinal Chemistry 42 1999 5029 5042
79. J.A. Lile, D. Morgan, A.M. Birmingham, Z. Wang, and W.L. Woolverton The reinforcing efficacy of the dopamine reuptake inhibitor 2beta-propanoyl-3beta- (4-tolyl)-tropane (PTT) as measured by a progressive-ratio schedule and a choice procedure in rhesus monkeys Journal of Pharmacology and Experimental Therapeutics 303 2002 640 648
80. Lima, M. S., Reisser, A. A., Soares, B. G., & Farrell, M. (2003). Antidepressants for cocaine dependence. Cochrane database of systematic reviews [computer file] CD002950(2).
81. N. Lintzeris, F. Holgate, and D. Dunlop Addressing dependent amphetamine use: A place for prescription Drug and Alcohol Review 15 1996 189 195
82. T. Llosa The standard low dose of oral cocaine: Used for treatment of cocaine dependence Substance Abuse 15 4 1994 215 220
83. T. Llosa Double-blind trials with oral cocaine as coca tablets (CTA) used for cocaine dependence treatment NIDA Research Monograph 153 1994 302
84. T. Llosa Cocalisation: The standard low dose of oral cocaine used as substitution therapy in cocaine dependence NIDA Research Monograph 174 1996 186
85. S.E. Lukas, J.E. Moreton, and N. Khazan Effects of levo-alpha- acetylmethadol (LAAM) on morphine self-administration in the rat Psychopharmacology 73 1981 12 16
86. M.J. Macenski, and R.A. Meisch Cocaine self-administration under conditions of restricted and unrestricted food access Experimental and Clinical Psychopharmacology 7 4 1999 324 327
87. R. Malcolm, and S. Brook Clinical applications of modafinil in stimulant abusers: Low abuse potential The American Journal on Addictions 11 2002 247 249
88. Malcolm, R., & Devane, J. (2003). Modafinil dampens multiple aspects of intravenous cocaine high. Paper presented at the The College on Problems of Drug Dependence: Abstracts of the Sixty-fifth Annual Scientific Meeting, Bal Harbor FL.
89. Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2003). Buprenorphine versus placebo or methadone maintenance for opioid dependence. [update of Cochrane Database Syst Rev 2002.]. Cochrane Database of Systematic Reviews [computer file], CD002207.
90. A.J. McBride, G. Sullivan, A.E. Blewett, and S. Morgan Amphetamine prescribing as a harm reduction measure: A preliminary study Addiction Research 5 2 1997 95 112
91. A. McNeill, J. Foulds, and C. Bates Regulation of nicotine replacement therapies (NRT): A critique of current practice Addiction 96 2001 1757 1768
92. R.A. Meisch Oral drug self-administration: An overview of laboratory animal studies Alcohol 24 2 2001 117 128
93. N.K. Mello, M.P. Bree, and J.H. Mendelson Comparison of buprenorphine and methadone effects on opiate self-administration in primates Journal of Pharmacology and Experimental Therapeutics 225 1983 378 386
94. N.K. Mello, S.E. Lukas, M.P. Bree, and J.H. Mendelson Desipramine effects on cocaine self-administration by rhesus monkeys Drug and Alcohol Dependence 26 1990 103 116
95. N.K. Mello, and S.S. Negus Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures Neuropsychopharmacology 14 6 1996 375 424
96. N.K. Mello, and S.S. Negus The effects of buprenorphine on self-administration of cocaine and heroin "speedball" combinations and heroin alone by rhesus monkeys Journal of Pharmacology and Experimental Therapeutics 285 2 1998 444 456
97. N.K. Mello, and S.S. Negus Interactions between kappa opioid agonists and cocaine. Preclinical studies Annals of the New York Academy of Sciences 909 2000 104 132
98. J.H. Mendelson, N.K. Mello, M.B. Sholar, A.J. Siegel, M.J. Kaufman, and F.R. Levin Cocaine pharmacokinetics in men and in women during the follicular and luteal phase of the menstrual cycle Neuropsychopharmacology 21 1999 294 303
99. Merrill, J., Tetlow, V. A. (1998). Prescribing for amphetamine users: Evaluation of a dexamphetamine substitution programme. Paper presented at the Beyond Oral Methadone: Expanded pharmacotherapies for the treatment of drug dependence, New York.
100. M. Mitcheson, G. Edwards, D. Hawks, and A. Ogbourne Treatment of methylamphetamine users during the 1986 epidemic G. Edwards M.A.H. Russell M. Macafferty Drugs and drug dependence 1976 Saxon House Publishers London 155 162
101. I.D. Montoya NIDA medication development program 2004 Bethesda, MD
102. D.F. Musto Illicit price of cocaine in two eras: 1908-14 and 1982-89 Connecticut Medicine 54 6 1990 321 326
103. D.F. Musto Opium, cocaine and marijuana in American history Scientific American 265 1 1991 40 47
104. D.F. Musto Cocaine's history, especially the American experience Ciba Foundation Symposium 166 1992 7 14 (discussion 14-19)
105. N.H. Mutschler, and J. Bergman Effects of chronic administration of the D1 receptor partial agonist SKF77434 on cocaine self-administration in rhesus monkeys Psychopharmacology 160 2002 362 370
106. E. Nann-Vernotica, D. E.C., G.E. Bigelow, and S.L. Walsh Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine Psychopharmacology 155 4 2001 338 347
107. Negus, S. S. (2002). Effects of continuous infusion with methamphetamine on cocaine self-administration and food maintained responding in rhesus monkeys. Paper presented at the American College of Neuropsychopharmacology, San Juan, Puerto Rico.
108. S.S. Negus Rapid assessment of choice between cocaine and food in rhesus monkeys: Effects of environmental manipulations and treatment with d-amphetamine and flupenthixol Neuropsychopharmacology 28 2003 919 931
109. Negus, S. S. (2004). Pharmacological modulation of choice between heroin and food in rhesus monkeys: Effects of naloxone, buprenorphine and methadone. Paper presented at the College on Problems of Drug Dependence, Bal Harbor FL.
110. S.S. Negus, M.R. Brandt, and N.K. Mello Effects of the long-acting monoamine reuptake inhibitor indatraline on cocaine self-administration in rhesus monkeys Journal of Pharmacology and Experimental Therapeutics 291 1 1999 60 69
111. S.S. Negus, and N.K. Mello Effects of chronic d-amphetamine treatment on cocaine- and food-maintained responding under a progressive ratio schedule in rhesus monkeys Psychopharmacology 167 2003 324 332
112. S.S. Negus, and N.K. Mello Effects of chronic d-amphetamine treatment on cocaine- and food maintained responding under a second-order schedule in rhesus monkeys Drug and Alcohol Dependence 70 2003 39 52
113. S.S. Negus, N.K. Mello, X. Lamas, and J.H. Mendelson Acute and chronic effects of flupenthixol on the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys Journal of Pharmacology and Experimental Therapeutics 278 2 1996 879 890
114. S.S. Negus, N.K. Mello, P.S. Portoghese, and C.E. Lin Effects of kappa opioids on cocaine self-administration by rhesus monkeys Journal of Pharmacology and Experimental Therapeutics 282 1 1997 44 55
115. Nunes, E. V. (1997). Methodologic recommendations for cocaine abuse clinical trials: A clinician-researcher's perspective (Vol. 175).
116. E.V. Nunes, P.J. McGrath, F.M. Quitkin, K. Ocepek-Welikson, J.W. Stewart, and T. Koenig Imipramine treatment of cocaine abuse: Possible boundaries of efficacy Drug and Alcohol Dependence 39 3 1995 185 195
117. G. O'Leary, and R.D. Weiss Pharmacotherapies for cocaine dependence Current Psychiatry Reports 2 6 2000 508 513
118. R. Paterson, C. Douglas, J. Hallmayer, M. Hagan, and Z. Krupenia A randomized, double blind, placebo controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder Australian and New Zealand Journal of Psychiatry 33 3 1999 494 502
119. R. Pates, N. Coombes, and N. Ford A pilot programme in prescribing dexamphetamine for amhetamine users (Part 1) Journal of Substance Misuse for Nursing, Health and Social Care 1 2 1996 80 84
120. I.L. Petrakis, and F.I. Carroll Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts Drug and Alcohol Dependence 50 3 1998 221 226
121. I.L. Petrakis, K.M. Carroll, C. Nich, L.T. Gordon, E.F. McCance-Katz, and T. Frankforter Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts Addiction 95 2 2000 219 228
122. H. Pickering, and G. Stimson Prevalence and demographic factors of stimulant use Addiction 89 1994 1385 1389
123. M. Pilla, S. Perachon, F. Sautel, F. Garrido, A. Mann, and C.G. Wermuth Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist Nature 400 6742 1999 371 375
124. D.M. Platt, J.S. Rodefer, J.K. Rowlette, and R.D. Spealman Suppression of cocaine- and food-maintained behavior by the D2-like receptor partial agonist terguride in squirrel monkeys Psychopharmacology 166 2003 298 305
125. D.M. Platt, J.K. Rowlette, and R.D. Spealman Modulation of cocaine and food self-administration by low- and high-efficacy D1 agonists in squirrel monkeys Psychopharmacology 157 2001 208 216
126. D.M. Platt, J.K. Rowlette, and R.D. Spealman Behavioral effects of cocaine and dopaminergic strategies for preclinical medication development Psychopharmacology 163 2002 265 282
127. J. Platt Cocaine addiction: Theory, research and treatment 1997 Harvard University Press Cambridge
128. R. Prien D. Robinson Clinical evaluation of psychotropic drugs 1994 Raven Press New York
129. R.A. Rettig A. Yarmolinsky Federal regulation of methadone treatment 1995 National Academy Press Washington, DC
130. J.D. Roache, J. Grabowski, J.M. Schmitz, D.L. Creson, and H.M. Rhoades Laboratory measures of methylphenidate effects in cocaine-dependent patients receiving treatment Journal of Clinical Psychopharmacology 20 1 2000 61 68
131. R.B. Rothman, B.E. Blough, and M.H. Baumann Appetite suppressants as agonist substitution therapies for stimulant dependence Annals of the New York Academy of Sciences 965 2002 109 126
132. R.B. Rothman, and J.R. Glowa A review of the effects of dopaminergic agents on humans, animals, and drug seeking behavior, and its implications for medication development: Focus on GBR12909 Molecular Neurobiology 10 1995 1 19
133. J. Schmitz, P. Averill, A. Stotts, F.G. Moeller, H. Rhoades, and J. Grabowski Fluoxetine treatment of cocaine-dependent patients with major depressive disorder Drug and Alcohol Dependence 63 3 2001 207 214
134. J. Schmitz, A.L. Stotts, H.M. Rhoades, and J. Grabowski Naltrexone and relapse prevention treatment for cocaine-dependence patients Addictive Behaviors 26 2 2001 167 180
135. H. Schubiner, K.K. Saules, C.L. Arfken, C.E. Johanson, C.R. Schuster, and N. Lockhart Double-blind placebo controlled trial of methylphenidate in the treatment of ADHD patients with comorbid cocaine dependence Experimental and Clinical Psychopharmacology 10 3 2002 286 294
136. J. Shearer, and L. Gowing Pharmacotherapies for problematic psychostimulant use: A review of current research Drug and Alcohol 2004 (in press)
137. Shearer, J., & Mattick, R. P. (2003). Feasibility, rationale and prospects for therapeutic cocaine vaccines.
138. J. Shearer, C.E. Sherman, A. Wodak, and I. van Beek Substitution therapy for amphetamine users Drug and Alcohol Review 21 2002 179 185
139. J. Shearer, A. Wodak, R.P. Mattick, I. van Beek, J. Lewis, and W. Hall A randomised controlled trial of feasibility of monitoring controlled prescribing of dexamphetamine. National Drug and Alcohol Research Centre NDARC Technical Report 75 1999 1 43
140. J. Shearer, A. Wodak, I. van Beek, R.P. Mattick, and J. Lewis Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence Addiction 98 2003 1137 1141
141. J.P. Sherman Dexamphetamine for "speed" addiction [letter] Medical Journal of Australia 153 1990 306
142. S. Shoptaw, P. Kintaudi, C. Charuvastra, and W. Ling A screening trial of amantadine as a medication for cocaine dependence Drug and Alcohol Dependence 66 3 2002 217 224
143. S. Shoptaw, X. Yang, E.J. Rotheram-Fuller, Y.C. Hsieh, P.C. Kintaudi, and V.C. Charuvastra Randomized placebo-controlled trial of baclofen for cocaine dependence: Preliminary effects for individuals with chronic patterns of cocaine use Journal of Clinical Psychiatry 64 12 2003 1440 1448
144. C. Silagy, T. Lancaster, L. Stead, D. Mant, and G. Fowler Nicotine replacement for smoking cessation (Cochrane Review) (Vol. 1) 2004 John Wiley and Sons Chichester
145. K. Silverman, M.A. Chutuape, G.E. Bigelow, and M.L. Stitzer Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: Effects of reinforcement magnitude Psychopharmacology 146 2 1999 128 138
146. D.D. Simpson, G.W. Joe, W. George, and K.M. Broome A national 5-year follow-up of treatment outcomes of cocaine dependence Archives of General Psychiatry 59 2002 538 544
147. B.G. Soares, M.S. Lima, A.A. Reisser, and M. Farrell Dopamine agonists for cocaine dependence (Cochrane Review) (Vol. CD003352) 2004 John Wiley and Sons Chichester
148. E. Somoza, and T. Winhusen An open label pilot study of methylphenidate in the treatment of cocaine dependent patients with adult attention deficit/hyperactivity disorder Journal of Addictive Diseases 23 1 2004 77 92
149. M. Srisurapanont, N. Jarusuraisin, and P. Kittirattanapaiboon Treatment for amphetamine dependence and abuse, Cochrane Review 2001 Oxford
150. D. Stafford, M.G. LeSage, and J.R. Glowa Effects of phentermine on responding maintained by progressive-ratio schedules of cocaine and food delivery in rhesus monkeys Behavioural Pharmacology 10 8 1999 775 784
151. D. Strug, and D. Hunt Patterns of cocaine use among methadone clients International Journal of the Addictions 20 8 1985 1163 1175
152. V.A. Tetlow, and J. Merrill Rapid determination of amphetamine stereoisomer ratios in urine by gas chromatography-mass spectroscopy Annals of Clinical Biochemistry 33 1996 50 54
153. F. Vocci, C.N. Chiang, L. Cummings, and R. Hawks Overview: Medications development for the treatment of drug abuse NIDA Research Monograph 149 1995 4 15
154. S.L. Walsh, K.A. Haberny, and G.E. Bigelow Modulation of intravenous cocaine effects by chronic oral cocaine in humans Psychopharmacology 150 2000 361 373
155. N.S. Wang, V.L. Brown, J. Grabowski, and R.A. Meisch Reinforcement by orally delivered methadone, cocaine, and methadone-cocaine combinations in rhesus monkeys: Are the combinations better reinforcers? Psychopharmacology 156 1 2001 63 72
156. B. Weiss, and V.G. Laties Enhancement of human performance by caffeine and the amphetamines Pharmacological Reviews 14 1-36 1962
157. R. White Dexamphetamine substitution in the treatment of amphetamine abuse: An initial investigation Addiction 95 2 2000 229 238
158. T.E. Wilens, S.V. Faraone, J. Biederman, and B.S. Gunawardene Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature Pediatrics 111 2003 179 185
159. G. Winger, and J.H. Wood Effects of buprenorphine on behaviour maintained by heroin and alfentanil in rhesus monkeys Behavioural Pharmacology 7 1996 155 159
160. F.H. Wojnicki, R.B. Rothman, K.C. Rice, and J.R. Glowa Effects of phentermine on responding maintained under multiple fixed-ratio schedules of food and cocaine presentation in the rhesus monkey Journal of Pharmacology and Experimental Therapeutics 288 1999 550 560